Wayne K. Langholff - AI Profile | 人才画像

基本信息

浏览量：34

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 92 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and Safety of Guselkumab in Patients with Active Psoriatic Arthritis Who Had Inadequate Efficacy And/or Intolerance to One Prior Tumor Necrosis Factor Inhibitor: Study Protocol for SOLSTICE, a Phase 3B, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Alexis Ogdie,Joseph F. Merola,Philip J. Mease,Christopher T. Ritchlin,Jose U. Scher,Kimberly Parnell Lafferty,Daphne Chan,Soumya D. Chakravarty,Wayne Langholff,Yanli Wang,Olivia Choi,Yevgeniy Krol,Alice B. Gottlieb

BMC RHEUMATOLOGYno. 1 (2024)

引用0浏览0WOS引用

54131 Malignancy Rates in Patients with a History of Malignancy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Richard G. Langley,David Fiorentino, Jerry Bagel,Kimberly Parnell Lafferty, Elizabeth Skobelev,Wayne Langholff,Mark Lebwohl,Vincent Ho,Bruce Strober

Journal of the American Academy of Dermatologyno. 3 (2024): AB61

引用0浏览0引用

54148 Characteristics of Real-world Patients with Psoriasis Prescribed Guselkumab or Interleukin-17 Inhibitors: Data from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Bruce Strober,Matthias Augustin,Yayoi Tada,Kimberly Parnell Lafferty, Elizabeth Skobelev,Wayne Langholff,Steven Fakharzadeh, Robert Gniadecki

Journal of the American Academy of Dermatologyno. 3 (2024): AB152

引用0浏览0引用

Efficacy and safety of intravenous ustekinumab re-induction therapy in crohn's disease patients with secondary loss of response to ustekinumab maintenance therapy: week 16 results from the power trial

Scott D. Lee,Stefan Schreiber,Christien Janneke,Van der Woude,Ignacio Marin-Jimenez,Douglas C. Wolf,Elisabeth Schnoy,Bruce Salzberg,Christopher Busse,Maciej Nazar,Wayne Langholff,Stephan Borghorst,Christopher Gasink,Thomas Baker,Bridget Godwin,Brian G. Feagan

GASTROENTEROLOGYno. 6 (2023): S220-S220

引用0浏览0引用

Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Melinda J. Gooderham,Robert Bissonnette,Sunil Kalia,Kim A. A. Papp,Lyn C. Guenther,Wayne P. Gulliver,Vincent Ho,Neil H. Shear,Ron Vender,Robert Gniadecki,Vimal H. Prajapati,Irina Turchin,Wayne Langholff, Kim Parnell, Scott D. Simpson,Nastaran Abbarin,Omair Lakhani,Raed Alhusayen

Journal of Cutaneous Medicine and Surgery（2023）

引用0浏览0WOS引用

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study

Clifton O. Bingham,Shawn Black,Natalie J. Shiff,Stephen Xu,Wayne Langholff,Jeffrey R. Curtis

Rheumatology and Therapy（2023）

引用0浏览0WOS引用

Effectiveness and Safety of Intravenous Golimumab with and Without Concomitant Methotrexate in Patients with Rheumatoid Arthritis in the Prospective, Noninterventional AWARE Study

Aaron Broadwell,Joy Schechtman,Douglas Conaway,Alan Kivitz,Natalie J. Shiff,Shawn Black,Stephen Xu,Wayne Langholff,Sergio Schwartzman,Jeffrey R. Curtis

BMC Rheumatologyno. 1 (2023)

引用0浏览0WOS引用

S1073 Clinical Outcomes and Biomarker Normalization Response at Week 16 in Patients with Inadequate Response or Intolerance to Prior Biologics in the POWER Trial

Scott D. Lee,Stefan Schreiber,C. Janneke van der Woude,Ignacio Marín-Jiménez,Douglas C. Wolf,Elisabeth Schnoy,Bruce Salzberg,Christopher Busse,Maciej Nazar,Wayne Langholff,Christopher Gasink,Thomas Baker,Bridget Godwin,Brian G. Feagan

American Journal of Gastroenterologyno. 10S (2023)

引用0浏览0引用

Analysis of Baseline Characteristics Associated with Clinical Response to Ustekinumab IV Re-Induction Strategy in Patients with Crohn's Disease in the POWER Trial

Douglas C. Wolf,Scott D. Lee,Stefan Schreiber,C. Janneke van der Woude,Ignacio Marin-Jimenez,Elisabeth Schnoy,Bruce Salzberg,Christopher Busse,Maciej Nazar,Wayne Langholff,Christopher Gasink,Thomas Baker,Bridget Godwin,Brian G. Feagan

AMERICAN JOURNAL OF GASTROENTEROLOGYno. 10 (2023): S786-S786

引用0浏览0引用

1027 EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB REINDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL

Scott D. Lee,Stefan Schreiber,Christien Janneke Van Der Woude,Ignacio Marin-Jimenez,Douglas C. Wolf,Elisabeth Schnoy,Bruce Salzberg,Christopher Busse,Maciej Nazar,Wayne Langholff, Stephan Borghorst,Christopher Gasink,Thomas Baker,Bridget Godwin,Brian G. Feagan

Gastroenterologyno. 6 (2023): S-220-S-221

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn